Elekta to accelerate revenue growth and sees continued strong EBIT growth

Elekta to accelerate revenue growth and sees continued strong EBIT
growth

Press Release
Stockholm, Sweden, June 9, 2011

Elekta's strategy will result in accelerated revenue growth and
continued strong EBIT growth. This was the message from Tomas Puusepp,
President and CEO at today's Capital Markets Day.

Following the release of Elekta's year-end report for 2010/11, Tomas
Puusepp described how Elekta is well positioned to drive growth in
several areas. “Our first priority is to accelerate growth from
delivering systems to solutions.” He says Elekta can increase market
share in established markets through extended solutions while investing
in emerging markets to capture growth opportunities. Puusepp also said
that strategic acquisitions could support growth areas.

“Our second priority is to increase margins and establish
industry-leading efficiency. This includes improving G&A efficiency and
driving higher margins by continuing to increase our sales in services
and software,” he said.

Puusepp revealed Elekta's strategy for sustainable profitable growth for
the coming years. In 2015 Elekta is foreseen to reach a revenue growth
of 13-15 percent. EBIT, earnings before interest and tax, is expected to
show continued strong growth, helped by a decrease in SG&A from 22 to 19
percent of net sales. Earnings per share is expected to have shown an
increase by more than 60 percent in year 2015 and net debt to equity is
expected to be below 0.5.

The Capital Markets Day is held on June 9 from 09.00 CET to 12.00 CET,
at the Museum of Modern Art in Stockholm. A webcast from the event will
be available on Elekta's website
(www.elekta.com (http://www.elekta.com)).
 

###
 

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, e-mail:
stina.thorman@elekta.com (stina.thorman@elekta.com)

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 9.00 CET on
June 9, 2011.

About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy and radiosurgery, as well as
workflow-enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that give confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in more
than 5,000 hospitals globally, and every day more than 100,000 patients
receive diagnosis, treatment or follow-up with the help of a solution
from the Elekta Group. Elekta employs about 2,800 employees globally.
The corporate headquarters is located in Stockholm, Sweden, and the
company is listed on the Nordic Exchange under the ticker EKTAb